Neonatal Autonomic Regulation as a Predictor of Autism Spectrum Disorder in Very Preterm Infants

INTRODUCTION

Infants born preterm are at a significantly higher likelihood of having autism spectrum disorder (ASD), with reports of a 10-fold increase in the rate of ASD for very preterm infants (VPT, born < 32 weeks gestation)¹ and a 20-fold increase for extremely preterm infants (born <28 weeks gestation)². Yet, the etiological link between preterm birth and ASD remains unknown. Preterm birth and ASD are both associated with neurological differences, notably autonomic nervous system (ANS) dysfunction, pointing to neonatal ANS dysfunction as a promising early biomarker and potential pathway to ASD, particularly in VPT infants. The current study describes preliminary findings from a prospective, longitudinal trial of VPT infants with continuous measures of autonomic dysregulation in the first month of life, comprehensive neurodevelopmental monitoring, and ASD follow-up at age 1 year.

METHODS

A subset of VPT infants enrolled in a large, multisite clinical trial³ were enrolled in this study at birth (N=20). Continuous measures of minute-by-minute thermal gradients, defined by the difference between central and peripheral temperatures³, and hour-by-hour abnormal heart rate characteristics (HRCs), measured using HeRO scores⁴, were collected from birth-28 days (>40,000 samples/infant). See additional details in Supplemental Information (SI). ANS dysfunction is indicated by abnormal HRCs (HeRO scores > 1) or elevated negative thermal gradients (peripheral > central body temperature)⁵. Following NICU discharge, standardized measures of cognition, language, and motor skills were collected at adjusted ages 6, 9, and 12 months (see SI). At 12 months, assessments of social communication and early ASD symptoms were administered^6–8 (see SI). Study procedures were approved by hospital and university institutional review boards. Univariate, multivariate, and robust regression models were used to evaluate neonatal predictors of ASD outcomes.

RESULTS

Descriptive statistics for all measures are presented in Tables 1 and S1. Continuous measures of ANS function were collected for N=20 infants enrolled at birth. Following NICU discharge, n=12 completed 1-year developmental follow-up (10 males) and n=1 was excluded from analyses due to significant medical morbidities that precluded a valid ASD assessment (see Fig. S1). Across all infants in the first 28 days of life, the average HeRO score was just above 1 and infants experienced abnormal negative thermal gradients for about 20% of the time (6 of 28 days). In terms of developmental trajectories, significant delays did not emerge until 12 months when over 50% of the sample exhibited social-communication delays and exceeded the clinical cutoff for ASD risk (see Table S1 and Fig S2). Neonatal abnormal HRCs were strongly associated with ASD symptoms at 12 months (r=0.81, p<.01; Fig. 1), as was birth gestational age (GA), birth weight (BW), and abnormal negative thermal gradients. A regression model including GA, BW, and abnormal HRCs revealed a significant, unique predictive effect of abnormal HRCs on ASD outcomes (model r=0.86, p=.017; HRC r=.72, p=.029).

• Download figure
• Open in new tab

Figure 1.

Association between neonatal abnormal heart rate characteristics (HRCs) and 1-year ASD symptoms. Higher scores indicate more HRC abnormality and more ASD symptoms. A) Ridgeline plot displaying the distribution of neonatal abnormal HRCs (HeRO scores) across participant ASD symptoms (SORF Composite score) at 1 year. B) Scatterplot and associated regression between neonatal abnormal HRCs (HeRO scores) across 1-year ASD symptoms (SORF Composite score).

DISCUSSION

This report represents the first prospective, longitudinal study to describe predictive associations between neonatal ANS dysfunction, developmental trajectories across the first year of life, and emerging ASD symptoms at 1 year in VPT infants. The clinical presentation for most infants reflected marked delays in social communication that did not emerge until 12 months.

Significant ASD concerns were present for half of the sample by 12 months. ANS measures collected in the first month of neonatal life, more than a year prior to the ASD evaluation, were surprisingly strong predictors of ASD. Existing research points to ANS dysfunction in ASD that can be characterized by an imbalance – sympathetic overactivation and/or parasympathetic underactivation^9,10. The strong association between ASD features and abnormal HRCs and, albeit to a lesser extent, abnormal thermal gradients, represents novel evidence contributing to an emerging theoretical model in which ANS imbalance in very early infancy may be an underlying etiological feature of ASD, particularly in VPT infants. Future studies should extend these preliminary findings by including infants born >32w GA, ANS measures that extend beyond the neonatal period, ASD outcomes at later ages, and larger sample sizes. Overall, these results highlight complementary ANS measures that describe how ANS dysfunction, likely resulting from an imbalance between the parasympathetic and sympathetic systems, may impact very early regulatory processes for neonates who later develop ASD. This finding offers a promising avenue for researching etiological mechanisms and biomarkers of ASD.

Conflicts of Interest

Authors have no conflicts of interest to disclose.

Availability of Data and Materials

Data is available upon request.

Funding

All phases of this study were supported by grants from the Carolina Autism and Neurodevelopment Research Center at the University of South Carolina and the NIH (R01NR017872; R21DC017252; K23MH120476).

Author Contributions

Drs. Jessica Bradshaw and Robin Dail conceptualized and designed the study and supervised all aspects of data collection and analysis. Drs. Jessica Bradshaw and Christian O’Reilly designed and executed the data analysis plan. Drs. Jessica Bradshaw, Robin Dail, and Christian O’Reilly drafted the initial manuscript and critically reviewed and revised the manuscript. Dr. Abbas Tavakoli contributed to data analysis and critically reviewed and revised the manuscript. Dr. Kayla Everhart, Elizabeth Dixon, and Amy Vinyard coordinated participant enrollment and retention, led data collection and data management, and critically reviewed and revised the manuscript. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.